Search results with tag "Voss d"

Nucleic Acid Vaccine Technologies: DNA and mRNA

Fig 3. Protective capacity of mRNA vaccine against lethal intracerebal (i.c.) rabies challenge infection. Schnee M, Vogel AB, Voss D, Petsch B, Baumhof P, et al. (2016) An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against

  Technologies, Acid, Vaccine, Nucleic, Voss, Nucleic acid vaccine technologies, Voss d